Establishing the effective use of 'naked' nucleic acids as vaccines would u
ndoubtedly be one of the most important advances in the history of vaccinol
ogy. While nucleic acids show much promise for use as Vaccine vectors in ex
perimental animals, not a single naked nucleic acid vector has been approve
d for use in humans, indeed, data from human clinical trials is scant: nucl
eic acid vaccines have not been clearly demonstrated to have any convincing
efficacy in the prevention or treatment of infectious disease or cancer. H
ere we illustrate possible mechanisms underlying effective nucleic acid vac
cination. we focus on progress that has been made in the improvement of the
ir function. Additionally, we identify promising new strategies and try to
forecast future developments that could lead to the real success of nucleic
acid vaccines in the prevention and treatment of human disease.